Dr. Benjamin Burke is a scientist who's research overlaps chemistry and biology by developing imaging agents for medical diagnosis. His work is focused on the chemical design of new drugs for cancer and heart imaging, with most of his work in radioactive drug design for imaging with the nuclear medicine technique Positron Emission Tomography (PET)
Molecular Imaging Post-Doctoral Research Assistant, University of Hull
University of Hull, PhD
University of Hull, BSc
Probing the limits of tetraazamacrocycle-glyoxal condensates as bidentate ligands for Cu2+, Euro. J. Inorg. Chem
o-Boronate and o-Trifluoroboratophenyl phosphonium salts supported by L-alpha-amino acid side chain, J. Org. Chem
Chelator free gallium-68 radiolabelling of silica coated iron oxide nanorods via surface interactions, Nanoscale
Boron-18F containing positron emission tomography radiotracers: Advances and Opportunities, Contrast Media Mol. Imaging
Final step gallium-68 radiolabelling of silica coated iron oxide nanorods as potenetial PET/MR multimodal imaging agents, Faraday Discussions
Recent advances in chelator design and labelling methodology for 68Ga radiopharmaceuticals, J. Labelled Comp. Radiopharm.
A benzimidazole functionalised DO3A chelator showing pH switchable coordination modes with lanthanide ions, Dalton trans.
New bifunctional chelators for Ga-68 complex formation, J. Labelled Comp. Radiopharm.
Rapid synthesis of cross-bridged cyclam chelators for copper(II) complex formation, Comptes Rendus Chimie